Anti-Angiogenesis Maintenance Therapy in Newly Diagnosed and Relapsed Ovarian Cancer: A Meta-analysis of Phase III Randomized Controlled Trials

Anti-Angiogenesis Maintenance Therapy in Newly Diagnosed and Relapsed Ovarian Cancer: A Meta-analysis of Phase III Randomized Controlled Trials

Aim: Anti-angiogenesis agents have been added as maintenance therapy in ovarian cancer over the past decade. The aim of this meta-analysis was to analyze the efficacy of anti-angiogenesis therapy in newly diagnosed and relapsed ovarian cancer.Methods: PubMed, Embase, and Cochrane databases were sear...

Full description

Bibliographic Details
Main Authors:	Yizi Wang, Shitai Zhang, Zixuan Song, Ling Ouyang, Yan Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-11-01
Series:	Frontiers in Pharmacology
Subjects:	anti-angiogenesis meta-analysis newly diagnosed ovarian cancer relapsed ovarian cancer adverse events
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.726278/full

Similar Items

PARP Inhibitors in Patients With Newly Diagnosed Advanced Ovarian Cancer: A Meta-Analysis of Randomized Clinical Trials
by: Yizi Wang, et al.
Published: (2020-08-01)

First-Line Treatment  with Olaparib for Early Stage BRCA-Positive Ovarian Cancer: May It Be Possible? Hypothesis Potentially Generating a Line of Research
by: Tomao F, et al.
Published: (2020-07-01)

Management of Relapsed/Refractory Epithelial Ovarian Cancer: Current Standards and Novel Approaches
by: Hao Lin, et al.
Published: (2007-12-01)

Optimising the treatment of the partially platinum-sensitive relapsed ovarian cancer patient
by: Nicoletta Colombo
Published: (2014-12-01)

New trends in diagnosing and treating ovarian cancer using nanotechnology
by: Juan Zhang, et al.
Published: (2023-04-01)

Practical aspects of treating relapsed BRCA-associated ovarian cancer
by: A. A. Rumyantse, et al.
Published: (2019-12-01)

A Theoretical View of Ovarian Cancer Relapse
by: Gonzalo H. Giornelli, et al.
Published: (2017-08-01)

Comprehensive Analysis of DNA Methyltransferases Expression in Primary and Relapsed Ovarian Carcinoma
by: Efthymia Papakonstantinou, et al.
Published: (2023-10-01)

Indicators of distress in newly diagnosed breast cancer patients
by: Andrea Chirico, et al.
Published: (2015-07-01)

Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments
by: Massimo Offidani, et al.
Published: (2021-02-01)

Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis
by: Francesca Bonello, et al.
Published: (2019-11-01)

New Achievements from Molecular Biology and Treatment Options for Refractory/Relapsed Ovarian Cancer—A Systematic Review
by: Cornelia Bachmann
Published: (2023-11-01)

The role of angiogenesis blockers in the treatment of metastatic ovarian cancer
by: M R Oganian, et al.
Published: (2013-12-01)

COVID-19 Impact on Newly Diagnosed Breast Cancers at Regional Cancer Centre, Thiruvananthapuram—An Audit
by: Geethu Babu, et al.

Hyperhomocysteinemia in Patients with Newly Diagnosed Primary Hypertension in Can Tho City, Vietnam
by: Son Kim Tran, et al.
Published: (2023-01-01)

Combined and expanded operations in patients with relapsed ovarian cancer and affected retroperitoneal lymph nodes
by: Kh. I. Mamazhonov, et al.
Published: (2020-08-01)

High Fear of Cancer Recurrence in Chinese Newly Diagnosed Cancer Patients
by: Xian Luo, et al.
Published: (2020-06-01)

Fear of progression among postoperative patients with newly diagnosed lung cancer: a cross-sectional survey in China
by: Ruiyun Chen, et al.
Published: (2023-05-01)

Serum Cotinine and Passive Smoking Status Associated with Non-Smoking Newly Diagnosed Women with Breast Cancer in Malaysia
by: Zunura’in Zahali, et al.
Published: (2021-01-01)

The impact of thrombocytosis on the long term outcomes in relapsed ovarian cancer
by: Irina Balescu, et al.
Published: (2023-03-01)

Tregs are involved in VEGFA/ VASH1-related angiogenesis pathway in ovarian cancer
by: Sijing Qiao, et al.
Published: (2023-06-01)

Prevalence of Prediabetes and Newly diagnosed Diabetes in Patients with HFpEF and HFrEF
by: Ahmad ELSharawy, et al.
Published: (2024-01-01)

Radiopharmaceutical Switch Maintenance for Relapsed Ovarian Carcinoma
by: Charles A. Kunos, et al.
Published: (2020-09-01)

Ixazomib combined with lenalidomide and dexamethasone chemotherapy for newly diagnosed multiple myeloma in China—Compared with bortezomib/lenalidomide/dexamethasone
by: Zhongjun Huo, et al.
Published: (2023-02-01)

Dietary compounds galangin and myricetin suppress ovarian cancer cell angiogenesis
by: Haizhi Huang, et al.
Published: (2015-05-01)

Maintenance Chemotherapy in Patients with Platinum-Sensitive Relapsed Epithelial Ovarian Cancer after Second-Line Chemotherapy
by: Yen-Fu Chen, et al.
Published: (2024-01-01)

The hallmarks of ovarian cancer: Focus on angiogenesis and micro-environment and new models for their characterisation
by: V. Heredia-Soto, et al.
Published: (2020-08-01)

Demographic, Clinical and Management Characteristics of Newly Diagnosed COPD Patients in Turkey: A Real-Life Study
by: Suerdem M, et al.
Published: (2020-02-01)

Statin use and the risk of ovarian and endometrial cancers: a meta-analysis
by: Yizi Wang, et al.
Published: (2019-07-01)

Anxiety and Depression in Newly Diagnosed Epilepsy: A Matter of Psychological History?
by: Natacha Forthoffer, et al.
Published: (2021-10-01)

High-Dose Chemotherapy in Children with Newly Diagnosed Medulloblastoma
by: Lucie Lafay-Cousin, et al.
Published: (2022-02-01)

Clinical characteristics and treatment outcomes of patients with newly diagnosed schizophrenia: A 4‐year single‐center experience in Saudi Arabia
by: Tahir Hakami
Published: (2022-06-01)

Hormone Receptor Expression in Primary and Recurrent High-Grade Serous Ovarian Cancer and Its Implications in Early Maintenance Treatment
by: Marcus Vetter, et al.
Published: (2022-11-01)

Genetic Perturbation of Pyruvate Dehydrogenase Kinase 1 Modulates Growth, Angiogenesis and Metabolic Pathways in Ovarian Cancer Xenografts
by: Carolina Venturoli, et al.
Published: (2021-02-01)

Novel inflammatory markers and prognostic importance of platinum-sensitive ovarian carcinoma relapse
by: Tay Fatih, et al.
Published: (2023-01-01)

Epidemiological factors associated with recent HIV infection among newly-diagnosed cases in Singapore, 2013-2017
by: Ang, Li Wei, et al.
Published: (2022)

Relapsed Ovarian Cancer Patients with Ascites and/or Pleural Effusion Still Benefit from Treatment: A Real-Life Study
by: Mariana Rebordão-Pires, et al.
Published: (2023-12-01)

Relapse of acute lymphoblastic leukemia presenting with ovarian torsion: A rare case report
by: Saket Patwardhan, et al.
Published: (2022-09-01)

Under-Treatment of Older Patients with Newly Diagnosed Epithelial Ovarian Cancer Remains an Issue
by: Lucy Dumas, et al.
Published: (2021-02-01)

CircATRNL1 activates Smad4 signaling to inhibit angiogenesis and ovarian cancer metastasis via miR‐378
by: Juan Wang, et al.
Published: (2021-04-01)